Trikafta Update: Webinar & Q&A


As you may be aware a new CFTR Modulator called Trikafta, also known as triple-combination therapy, was approved in June 2021 for use in Canada. Our clinic is working diligently to access this medication for our 375+ patients who are eligible. While we have created an FAQS list available by email bounce back at we anticipate you may have further questions so have organized a Trikafta Update: Webinar/ Q&A in the coming weeks. We ask that you forward any questions in advance to so we may prepare for the session. Details: Event: Trikafta Update: Webinar/ Q&A Date: Wednesday [...]